100 related articles for article (PubMed ID: 813018)
1. Prostatic cancer revisited.
Cosgrove MD; Kaempf MJ
J Urol; 1976 Jan; 115(1):79-81. PubMed ID: 813018
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with supervoltage radiotherapy in carcinoma of the prostate: a preliminary report.
Mollenkamp JS; Cooper JF; Kagan AR
J Urol; 1975 Mar; 113(3):374-7. PubMed ID: 804044
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostics and therapy of the carcinoma of the prostate (author's transl)].
Schnorr D; Guddat HM; Neuser D; Correns HJ; Dörner G; Mau S
Zentralbl Chir; 1979; 104(7):436-45. PubMed ID: 112805
[TBL] [Abstract][Full Text] [Related]
4. Treatment of stage 1 carcinoma of the prostate: a preliminary report.
Blackard CE; Mellinger GT; Gleason DF
J Urol; 1971 Nov; 106(5):729-33. PubMed ID: 5115730
[No Abstract] [Full Text] [Related]
5. The questionable use of hormone therapy in advanced carcinoma of the prostate.
Murphy GP; Slack NH
Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
[No Abstract] [Full Text] [Related]
6. Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma.
Paulson DF; Cline WA; Koefoot RB; Hinshaw W; Stephani S
J Urol; 1982 May; 127(5):935-7. PubMed ID: 6806486
[TBL] [Abstract][Full Text] [Related]
7. [Castration in the treatment of locally advanced or metastatic prostate cancer].
Mongiat-Artus P
Rev Prat; 2013 Apr; 63(4):509-10. PubMed ID: 23682480
[No Abstract] [Full Text] [Related]
8. Endocrine treatment of cancer of the prostate.
Madsen PO; Pedersen JF; Knuth OE
Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
[No Abstract] [Full Text] [Related]
9. Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging.
Gleason DF; Mellinger GT;
J Urol; 2017 Feb; 197(2S):S134-S139. PubMed ID: 28012760
[No Abstract] [Full Text] [Related]
10. Carcinoma of the prostate: reasons for endocrine treatment prior to symptomatic metastases.
Chisholm GD
Prog Clin Biol Res; 1990; 359():1-6; discussion 15-24. PubMed ID: 2284285
[No Abstract] [Full Text] [Related]
11. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
Gleason DF; Mellinger GT
J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
[No Abstract] [Full Text] [Related]
12. Lymph node involvement in prostatic carcinoma.
Varkarakis MJ; Murphy GP; Nelson CM; Chehval M; Moore RH; Flocks RH
Urol Clin North Am; 1975 Feb; 2(1):197-212. PubMed ID: 1128748
[No Abstract] [Full Text] [Related]
13. Radiation therapy versus delayed androgen deprivation for stage C carcinoma of the prostate.
Paulson DF; Hodge GB; Hinshaw W
J Urol; 1984 May; 131(5):901-2. PubMed ID: 6423840
[TBL] [Abstract][Full Text] [Related]
14. Combined external radiotherapy and hormonal therapy for localized carcinoma of the prostate.
Mukamel E; Servadio C; Lurie H
Prostate; 1983; 4(3):283-7. PubMed ID: 6844159
[TBL] [Abstract][Full Text] [Related]
15. Current concepts concerning carcinoma of the prostate.
Skinner DG
Surg Annu; 1973; 5():393-406. PubMed ID: 4602222
[No Abstract] [Full Text] [Related]
16. The value of cytology for the follow-up of prostatic cancer after hormone and irradiation therapy.
Bandhauer K; Spieler P
Eur Urol; 1985; 11(4):224-7. PubMed ID: 3930251
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
[TBL] [Abstract][Full Text] [Related]
18. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
[TBL] [Abstract][Full Text] [Related]
19. [Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group].
Masai M; Akimoto S; Isaka S; Shimazaki J; Yatani R
Hinyokika Kiyo; 1990 Jun; 36(6):667-71. PubMed ID: 1700585
[TBL] [Abstract][Full Text] [Related]
20. Followup of irradiated prostatic carcinoma by aspiration biopsy.
Kurth KH; Altwein JE; Skoluda D; Hohenfellner R
J Urol; 1977 May; 117(5):615-7. PubMed ID: 870712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
